January 8, 2026: Quality of Life and Patient Experience With BCMA-Directed Therapies in Multiple Myeloma

January 8, 2026

Welcome to the fourth session of our ECHO program!

Quality of Life and Patient Experience With BCMA-Directed Therapies in Multiple Myeloma

Target Audience:
Oncologists, hematologists, PAs, NPs, nurses, nurse navigators, pharmacists and other healthcare professionals (HCPs) responsible for the care and treatment of people living with RRMM.

Please click on: Take Course the day of the session to access the zoom link.

Learning Objectives:

  • Recognize the physical, emotional, and social quality of life (QoL) of patients treated with BCMA targeting BsABs
  • Evaluate tools and strategies for assessing patient-reported outcomes and quality of life
  • Develop personalized support plans that integrate multidisciplinary resources



Grantor Acknowledgement
This activity is supported by educational grants from Pfizer Inc., AbbVie Inc, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Course opens: 
06/02/2025
Course expires: 
03/09/2026
Event starts: 
01/08/2026 - 7:00pm EST
Event ends: 
01/08/2026 - 8:00pm EST
Part of: 
Multiple Myeloma (MM) ECHO®: Advancing RRMM Care Through Communities of Practice: Educating Community-Based Hematologic/Oncologic Teams on the Use of BCMA-Directed BsAbs
Add to calendar: 
Rating: 
0

 Jenny Ahlstrom
 Chief Executive Officer
 HealthTree Foundation

 Jenny Ahlstrom is a wife, mother of 6 and multiple myeloma patient diagnosed in 2010. In her own myeloma journey, she identified gaps in services she believed could help patients better navigate their care while inviting patients to help accelerate a myeloma cure. Jenny grew up in the San Francisco Bay Area, working for Hewlett Packard and then IBM as a mid-range Systems Engineer and Marketing Rep for healthcare software. She has been involved with tech startups over the last 30 years, supporting her husband Paul who is an entrepreneur, venture capitalist and private equity investor. Together, they used their tech and startup experience to solve significant problems in cancer research through the lens of a patient.


After her diagnosis, Jenny launched the HealthTree Foundation in 2012 to create new strategies and approaches to accelerate research using cutting-edge technology. This included the creation of novel software platforms called HealthTree Cure Hub (for patients) and HealthTree Research Hub (for researchers).

Ms. Jenny Ahlstrom has no relevant financial relationships to disclose.

 

Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Accreditation Statement
This activity is developed as a joint collaboration among Boston University Chobanian & Avedisian School of Medicine, Med-IQ, the AAPA, the Association of PAs in Oncology (APAO), and HealthTree Foundation.



In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.



Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

  American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit
  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.



Nurse Accreditation
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.




Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.

 



Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Please login or register to take this course.


Thank you for registering for our first session!

Once you have participated in the meeting, click on the link provided in the chat or in your calendar invite to come back here. Click on "Take Course" above to complete the evaluation and claim credit.

Please contact [email protected] with any questions of if you need assistance.